AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
The Fundamental Theses For Revising The Albanian Strategy Amid The Transformation Of Transatlantic Relations – Analysis

The Fundamental Theses For Revising The Albanian Strategy Amid The Transformation Of Transatlantic Relations – Analysis

US Exempts Select Indian Specialty Drugs From Tariff

US Exempts Select Indian Specialty Drugs From Tariff

Motherwitch’ by Award-Winning Director Minos Papas Set to Open in Cyprus

Motherwitch’ by Award-Winning Director Minos Papas Set to Open in Cyprus

Pharma stocks: Sun Pharma, Dr Reddy’s, Cipla, Biocon and others in focus today; here's why 

Pharma stocks: Sun Pharma, Dr Reddy’s, Cipla, Biocon and others in focus today; here's why 

Case Keenum, Bears score 'MNF' win over Eagles; MLB Wild Card preview; WNBA awards top rookie

Case Keenum, Bears score 'MNF' win over Eagles; MLB Wild Card preview; WNBA awards top rookie

Bangladesh among 20 countries gets US tariff relief on select specialty pharmaceuticals

Bangladesh among 20 countries gets US tariff relief on select specialty pharmaceuticals

US Waives Tariffs on Specialty Drugs from India and Other Countries
Wider Europe Briefing: Will The EU Soon Lift Potash Sanctions On Belarus?

Wider Europe Briefing: Will The EU Soon Lift Potash Sanctions On Belarus?

US grants India tariff relief on specialty drugs

US grants India tariff relief on specialty drugs

Bulgaria, Greece, Romania Sign Action Plan for Joint Transport Projects

Bulgaria, Greece, Romania Sign Action Plan for Joint Transport Projects

US 100% pharma tariff: Amid uncertainty, India gets exemption for select specialty drugs and ingredients

US 100% pharma tariff: Amid uncertainty, India gets exemption for select specialty drugs and ingredients

India gets US speciality-drug tariff relief

India gets US speciality-drug tariff relief

Big relief for Indian pharma: US puts India among 20 countries getting 0% tariff on select speciality drugs

Big relief for Indian pharma: US puts India among 20 countries getting 0% tariff on select speciality drugs

US tariff relief for India: Speciality drugs, gene therapies get 100% duty exemption

US tariff relief for India: Speciality drugs, gene therapies get 100% duty exemption

Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugs

Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugs

Baku becomes a hub for global investment

Baku becomes a hub for global investment

US exempts India, 19 other nations from 100% tariff on speciality drugs

US exempts India, 19 other nations from 100% tariff on speciality drugs

U.S. waives tariffs on certain speciality drugs from 20 countries, including India

U.S. waives tariffs on certain speciality drugs from 20 countries, including India

The U.S. and China Agree to Slash Tariffs

The U.S. and China Agree to Slash Tariffs

EXCLUSIVE: Commission to propose radical decision-making overhaul for larger EU

EXCLUSIVE: Commission to propose radical decision-making overhaul for larger EU

Sign up for:

Industry Gazette North Macedonia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Industry Gazette North Macedonia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.